Advertising Policy

 

Scivision Publishing Group LLC Journals accepts advertising for their hard copies, web sites and related e-mail services (e-mail alerts) according to the following principles:

  • Advertising must be separate from content. Content may not be altered, added, or deleted to accommodate advertising. Advertisers have no input regarding any of our editorial decisions or advertising policies. The advertising sales representatives have neither control over, nor prior knowledge of, specific editorial content before it is published.
     
  • Scivision Publishing Group LLC reserves the right to decline or cancel any advertisement at any time.
     
  • Third-party advertisements may not use Scivision Publishing Group LLC name, logo, or title on their web pages or email alerts.
     
  • Advertised products must be compliant with the regulations in the country where the advertisement will be seen. Advertisements for pharmaceutical products (including new drug applications) that are subject to U.S. Food and Drug Administration oversight must comply with FDA regulations regarding advertising and promotion.
     
  • Users will be able to distinguish advertising and editorial content clearly on the web site and in e-mail alerts. Commercial advertising does not appear on the same screen as editorial content on the web site or in full-content e-mails.
     
  • Advertisers have no control or influence over the results of searches a user may conduct on Journal web pages.
 
 
Most Viewed Article
  • Pomalidomide-Associated Progressive Multifocal Leukoencephalopathy (PML) in a Patient with IgG-κ Multiple Myeloma (MM)
    Cassataro G, Smorlesi G, Miceli G, Ruscica F, Alaimo V, Volpe V, Burlon R, Fertitta E, Canale C, Tomaiuolo L, Stella M, Grimaldi LM, Renda M.
    » Abstract » doi: 10.33425/2832-4226/23011

  • The Prevalence of Coronary Artery Disease in Amyloidosis Is 23%
    Lucianne Alers Sanchez, Napatkamon Ayutyanont, Erica Junqueira, Farzad Majidi, Hossein Akhondi.
    » Abstract » doi: 10.33425/2832-4226/23010

  • Haematological Profiles of Plasmodium-Induced Changes in Serum Amyloid-A levels among the Internally Displaced Persons in Maiduguri
    EZE Chinwe N, EBENEZER Amawulu.
    » Abstract » doi: 10.33425/2832-4226/23009

  • Gastritis, Gastropathy and Gastroprotection: What is Common and what are the Differences
    Marakhouski Yury, Rubens Juris.
    » Abstract » doi: 10.33425/2832-4226/23008

  • Mesenchymal Stem Cell-Based Therapy: Targeting Triple-Negative Breast Cancer
    Heather A. Domby, Vincent S. Gallicchio.
    » Abstract » doi: 10.33425/2832-4226/23007

Most Downloaded
  • Pomalidomide-Associated Progressive Multifocal Leukoencephalopathy (PML) in a Patient with IgG-κ Multiple Myeloma (MM)
    Cassataro G, Smorlesi G, Miceli G, Ruscica F, Alaimo V, Volpe V, Burlon R, Fertitta E, Canale C, Tomaiuolo L, Stella M, Grimaldi LM, Renda M.
    » Abstract » doi: 10.33425/2832-4226/23011

  • The Prevalence of Coronary Artery Disease in Amyloidosis Is 23%
    Lucianne Alers Sanchez, Napatkamon Ayutyanont, Erica Junqueira, Farzad Majidi, Hossein Akhondi.
    » Abstract » doi: 10.33425/2832-4226/23010

  • Haematological Profiles of Plasmodium-Induced Changes in Serum Amyloid-A levels among the Internally Displaced Persons in Maiduguri
    EZE Chinwe N, EBENEZER Amawulu.
    » Abstract » doi: 10.33425/2832-4226/23009

  • Gastritis, Gastropathy and Gastroprotection: What is Common and what are the Differences
    Marakhouski Yury, Rubens Juris.
    » Abstract » doi: 10.33425/2832-4226/23008

  • Mesenchymal Stem Cell-Based Therapy: Targeting Triple-Negative Breast Cancer
    Heather A. Domby, Vincent S. Gallicchio.
    » Abstract » doi: 10.33425/2832-4226/23007